Change in SEQENS' Shareholding Structure

This exit results in a multiple of nearly 2.9x and an IRR of approximately 40%.

Eurazeo, Merieux Equity Partners, Ardian and Eximium have sold their stake in Seqens to SK Capital Partners, with a partial reinvestment of the...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending a marketing...